InsiderTrades

Form 4/A for TRLV Trulieve Cannabis Corp.

Accepted 2021-10-28 00:00:00 ET · period of report 2021-09-29 · accession 0001754195-21-000071 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2021-10-28 2021-09-29 TRLV Rivers Kim A. Pres, CEO, Dir, 10% A - Grant $0.00 +52.1K 2.42M +2% $0
DA 2021-10-28 2021-09-29 TRLV Rivers Kim A. Pres, CEO, Dir, 10% A - Grant $0.00 +173.0K 173.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Subordinate Voting Shares 2021-09-29 A A 52,083 $0.00 2,418,740 D — — (F2) This amendment updates the number of shares beneficially owned after the reported transaction to reflect an additional 50 subordinate voting shares held by the reporting person, which were not reflected in the Form 3 filed on February 4, 2021, due to a clerical error.
2 Derivative Stock Option (Right to Buy) 2021-09-29 A A 172,962 $0.00 172,962 D $26.88 · — to 2028-09-29 172,962 Subordinate Voting Shares (F3) The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2021, one-third vesting on December 1, 2022 and one-third vesting on December 1, 2023. (F4) The original Form 4 filed on September 30, 2021 is amended by this Form 4 amendment to correct the expiration date, which was incorrectly reported in the original filing due to a clerical error.